Education
About Us
Working with TipRanks
Follow Us
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
NVCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.44 - $12.10
Previous CloseN/A
Volume31.37K
Average Volume (3M)116.15K
Market Cap
$181.43M
Enterprise Value$91.21M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.21
Next Earnings
Mar 11, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.14
Shares Outstanding23,904,474
10 Day Avg. Volume128,432
30 Day Avg. Volume116,148
Standard Deviation0.20
R-Squared0.00278
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-15.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.50
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-3.98
Enterprise Value/Ebitda-4.50
Forecast
1Y Price Target
$14.50Price Target Upside116.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Nuvectis Pharma News
PremiumCompany Announcements
Nuvectis Pharma Reports 2024 Financial Results and Progress
---
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentNXP900 is demonstrating a positive clinical profile and plans are in place to begin the Phase 1b portion in mid-2025.
Financial PerformanceManagement expects a cash runway into 2027 with pro forma cash of approximately $34 million.
Safety And EfficacyImprovement to safety outcomes using the optimized dosing strategies is encouraging.
Bears Say
---
Ownership Overview
42.20% Insiders
1.62% Mutual Funds
1.92% Other Institutional Investors
52.86% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVCT FAQ
What was Nuvectis Pharma’s price range in the past 12 months?
Nuvectis Pharma lowest stock price was $4.44 and its highest was $12.10 in the past 12 months.
What is Nuvectis Pharma’s market cap?
Nuvectis Pharma’s market cap is $181.43M.
When is Nuvectis Pharma’s upcoming earnings report date?
Nuvectis Pharma’s upcoming earnings report date is Mar 11, 2025 which is in 10 days.
How were Nuvectis Pharma’s earnings last quarter?
Nuvectis Pharma released its earnings results on Feb 25, 2025. The company reported -$0.35 earnings per share for the quarter, missing the consensus estimate of -$0.253 by -$0.097.
Is Nuvectis Pharma overvalued?
According to Wall Street analysts Nuvectis Pharma’s price is currently Undervalued.
Does Nuvectis Pharma pay dividends?
Nuvectis Pharma does not currently pay dividends.
What is Nuvectis Pharma’s EPS estimate?
Nuvectis Pharma’s EPS estimate is -0.25.
How many shares outstanding does Nuvectis Pharma have?
Nuvectis Pharma has 23,904,474 shares outstanding.
What happened to Nuvectis Pharma’s price movement after its last earnings report?
Nuvectis Pharma reported an EPS of -$0.35 in its last earnings report, missing expectations of -$0.253. Following the earnings report the stock price went down -5.842%.
Which hedge fund is a major shareholder of Nuvectis Pharma?
Currently, no hedge funds are holding shares in NVCT
---
Nuvectis Pharma Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.50 (116.74% Upside)
$14.50 (116.74% Upside)
Blogger Sentiment
Neutral
NVCT Sentiment 50%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-31.32%
12-Months-Change
Fundamentals
Return on Equity
-173.41%
Trailing 12-Months
Asset Growth
-3.01%
Trailing 12-Months
Company Description
Nuvectis Pharma
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its pipeline products include NXP800, NXP900.
---
NVCT Stock 12 Month Forecast
Average Price Target
$14.50
▲(116.74% Upside)
Technical Analysis
Best Analysts Covering NVCT
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+0.80%
reiterated a buy rating 5 days ago
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +0.80% per trade.
---